Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Federal Circuit upholds Humira invalidity finding
Americas
The US Court of Appeals for the Federal Circuit has upheld a district court’s decision to invalidate a patent covering arthritis treatment Humira, after a challenge by biopharmaceutical company AbbVie.   9 April 2015
Americas
A US hedge fund manager and a company he created has taken aim at Jazz Pharmaceuticals in an inter partes review patent challenge, marking the third time he has challenged a company’s patents.   9 April 2015
MSD targets Apotex in Nasonex infringement action
Americas
Merck Sharp & Dohme has sued Apotex at the US District Court for the District of New Jersey for allegedly infringing a patent covering hay fever nasal spray Nasonex.   8 April 2015
Americas
US anti-cancer company Juno Therapeutics and a children’s hospital have settled their patent licensing suit with pharmaceutical business Novartis and the trustees of the University of Pennsylvania.   7 April 2015
Americas
Law firm Kramer Levin Naftalis & Frankel has hired life sciences attorneys Brian Slater and Gregory Sephton.   7 April 2015
Americas
Law firm Schiff Hardin has added Cindy Ahn as counsel in its intellectual property practice group.   2 April 2015
Americas
Forest Labs, a subsidiary of Actavis, has sued InvaGen for allegedly infringing four patents covering depression drug Viibryd, in what is the fifth related lawsuit.   1 April 2015
Americas
A US appeals court has overturned a district court's decision to deny Apotex's request for a declaratory judgment that its proposed generic blood pressure drug would not infringe a patent owned by pharmaceutical company Daiichi Sankyo.   1 April 2015
Asia
The Indian government is “seriously considering” extending the term of data exclusivity protection for agrochemical inventions from three to five years, it has been claimed.   1 April 2015
Americas
Purdue Pharma has sued Collegium Pharmaceutical for allegedly infringing four of its patents relating to extended release painkiller OxyContin.   1 April 2015